This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul;4(7):e278-e279.

doi: 10.1016/S2352-3018(17)30072-3. Epub 2017 Apr 13.

Another statin option in HIV

Philip E Tarr¹, Helen Kovari²

Affiliations

Affiliations

¹ University Department of Medicine, Kantonsspital Baselland, University of Basel, Bruderholz 4101, Switzerland. Electronic address: philip.tarr@unibas.ch.
² Division of Infectious Diseases, University Hospital Zurich, University of Zurich, Switzerland.

PMID: 28416196
DOI: 10.1016/S2352-3018(17)30072-3

Comment

Another statin option in HIV

Philip E Tarr et al. Lancet HIV. 2017 Jul.

. 2017 Jul;4(7):e278-e279.

doi: 10.1016/S2352-3018(17)30072-3. Epub 2017 Apr 13.

Authors

Philip E Tarr¹, Helen Kovari²

Affiliations

¹ University Department of Medicine, Kantonsspital Baselland, University of Basel, Bruderholz 4101, Switzerland. Electronic address: philip.tarr@unibas.ch.
² Division of Infectious Diseases, University Hospital Zurich, University of Zurich, Switzerland.

PMID: 28416196
DOI: 10.1016/S2352-3018(17)30072-3

No abstract available

PubMed Disclaimer

Comment on

Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
Aberg JA, Sponseller CA, Ward DJ, Kryzhanovski VA, Campbell SE, Thompson MA. Aberg JA, et al. Lancet HIV. 2017 Jul;4(7):e284-e294. doi: 10.1016/S2352-3018(17)30075-9. Epub 2017 Apr 13. Lancet HIV. 2017. PMID: 28416195 Clinical Trial.

Similar articles

The role of statins in the setting of HIV infection.
Eckard AR, McComsey GA. Eckard AR, et al. Curr HIV/AIDS Rep. 2015 Sep;12(3):305-12. doi: 10.1007/s11904-015-0273-9. Curr HIV/AIDS Rep. 2015. PMID: 26126687 Free PMC article. Review.
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study.
Ciaffi L, Cavassini M, Genne D, Delhumeau C, Spycher Elbes R, Hill A, Wandeler G, Fehr J, Stoeckle M, Schmid P, Hirschel B, Montecucco F, Calmy A; Swiss HIV Cohort Study. Ciaffi L, et al. Eur J Clin Invest. 2015 Jul;45(7):720-30. doi: 10.1111/eci.12464. Eur J Clin Invest. 2015. PMID: 25989829 Clinical Trial.
Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
Ou HT, Chang KC, Li CY, Yang CY, Ko NY. Ou HT, et al. Int J Cardiol. 2017 Mar 1;230:592-598. doi: 10.1016/j.ijcard.2016.12.050. Epub 2016 Dec 21. Int J Cardiol. 2017. PMID: 28062146
Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin?
Stein JH. Stein JH. Top Antivir Med. 2016 Dec-2017 Jan;23(5):169-73. Top Antivir Med. 2016. PMID: 27398770 Free PMC article. Review.
Exploring Statins to Decrease HIV-Related Heart Disease Risk.
Mitka M. Mitka M. JAMA. 2015 Aug 18;314(7):657-9. doi: 10.1001/jama.2015.5498. JAMA. 2015. PMID: 26222872 No abstract available.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information